BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10673559)

  • 1. Recycling and refilling of transmitter quanta at the frog neuromuscular junction.
    Van der Kloot W; Colasante C; Cameron R; Molgó J
    J Physiol; 2000 Feb; 523 Pt 1(Pt 1):247-58. PubMed ID: 10673559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
    Naves LA; Van der Kloot W
    J Physiol; 2001 May; 532(Pt 3):637-47. PubMed ID: 11313435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased.
    Van der Kloot W; Molgó J; Cameron R; Colasante C
    J Physiol; 2002 Jun; 541(Pt 2):385-93. PubMed ID: 12042346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbonyl cyanide m-chlorophenylhydrazone on quantal transmitter release and ultrastructure of frog motor nerve terminals.
    Molgo J; Pecot-Dechavassine M
    Neuroscience; 1988 Feb; 24(2):695-708. PubMed ID: 2834667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP; Van der Kloot W
    J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoethylcholine as a false transmitter precursor at the frog and mouse neuromuscular junctions.
    Naves LA; Balezina OP; Van der Kloot W
    Brain Res; 1996 Aug; 730(1-2):58-66. PubMed ID: 8883889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of potassium on exocytosis of transmitter at the frog neuromuscular junction.
    Ceccarelli B; Fesce R; Grohovaz F; Haimann C
    J Physiol; 1988 Jul; 401():163-83. PubMed ID: 2902217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of L-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction.
    Searl T; Prior C; Marshall IG
    Neuroscience; 1990; 35(1):145-56. PubMed ID: 2141672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for the dynamic formation of transmitter quanta at the neuromuscular junction.
    Vautrin J; Kriebel ME; Holsapple J
    J Neurosci Res; 1992 Jun; 32(2):245-54. PubMed ID: 1357188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of quantal secretion induced by ouabain and its correlation with depletion of synaptic vesicles.
    Haimann C; Torri-Tarelli F; Fesce R; Ceccarelli B
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1953-65. PubMed ID: 3932368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release.
    Robitaille R; Tremblay JP
    Neuroscience; 1991; 40(2):571-85. PubMed ID: 1674115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitter packaging at frog neuromuscular junctions exposed to anticholinesterases; the role of second-stage acetylcholine loading.
    Naves LA; Van der Kloot W
    J Neurophysiol; 1996 Oct; 76(4):2614-25. PubMed ID: 8899632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intracellular Ca2+ in stimulation-induced increases in transmitter release at the frog neuromuscular junction.
    Zengel JE; Sosa MA; Poage RE; Mosier DR
    J Gen Physiol; 1994 Aug; 104(2):337-55. PubMed ID: 7807052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of black widow spider venom and Ca2+ on quantal secretion at the frog neuromuscular junction.
    Fesce R; Segal JR; Ceccarelli B; Hurlbut WP
    J Gen Physiol; 1986 Jul; 88(1):59-81. PubMed ID: 3488369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with hypertonic solutions increases quantal size at the frog neuromuscular junction.
    Van der Kloot W
    J Neurophysiol; 1987 May; 57(5):1536-54. PubMed ID: 3035113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between quantal secretion and vesicle loss at the frog neuromuscular junction.
    Hurlbut WP; Iezzi N; Fesce R; Ceccarelli B
    J Physiol; 1990 Jun; 425():501-26. PubMed ID: 2120425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.